Skip to content

A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus

Diabetes Follow-up Study for REduction of cardiovAscular outcoMes: a Coronary Computed Tomographic Angiography Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05801432
Acronym
DREAM-CCTA
Enrollment
511
Registered
2023-04-06
Start date
2021-08-24
Completion date
2026-12-31
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The purpose of this study is to evaluate the natural history of coronary atherosclerosis development and progression over time by CCTA and to identify risk factors attributable to the development of coronary atherosclerosis in a Korean DM population.

Detailed description

Patients with diabetes mellitus, who underwent initial CCTA (coronary computed tomographic angiography) at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012, will be evaluated for inclusion in the study. All DREAM-CCTA study patients will undergo follow-up CCTA based on order from their primary physician. CCTA and demographic data, medical history, cardiovascular risk factors, and laboratory data was collected in case report forms at the time of the initial CCTA and at the time of follow-up CCTA.

Interventions

None listed

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 19 years or older * Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012 * Willing and able to provide informed written consent

Exclusion criteria

* Blood test results that the Creatinine level exceeds 1.5 mg/dL * A person with a history of anaphylaxis or allergic shock associated with a contrast medium * Pregnant women * Unable to undergo follow-up CCTA * Uninterpretable CCTA

Design outcomes

Primary

MeasureTime frameDescription
The change in coronary atherosclerosis detected by initial and follow-up CCTAabout 10 years after first CCTAthe natural history of coronary atherosclerotic plaque development and progression over time by CCTA

Countries

South Korea

Contacts

CONTACTJi Sue HONG, RN
sue5165@naver.com82 2-2045-3798
CONTACTSeung-Whan Lee, MD
seungwlee@amc.seoul.kr82 2-3010-3170

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026